Company Profiles

driven by the PitchBook Platform

Amorphical

2004 FOUNDED
PRIVATE STATUS
Angel LATEST DEAL TYPE
$1.2M LATEST DEAL AMOUNT
Description

Manufacturer of dietary pharmaceutical products. The company develops and manufactures dietary supplements and drugs for the treatment and prevention of human metabolic bone disease (MBD). It specializes in manufacturing a unique form of calcium called amorphous calcium carbonate (ACC). The company's R&D pipeline also includes clinical trials of ACC-based products for the treatment of osteoporosis, hypoparathyroidism, and cancer-related bone metastasis.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Food Products
Pharmaceuticals
Primary Office
  • 11 Haharash Street
  • Ness-Ziona 7403118
  • Israel

+972 00-000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Amorphical’s full profile, request a free trial.

Amorphical Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 17-Mar-2014 $1.2M 00.00 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Amorphical Executive Team (1)

Name Title Board
Seat
Contact
Info
Yossi Ben Founder & Chief Executive Officer

Amorphical Board Members (1)

Name Representing Role Since Contact
Info
Netta Cohen Self Board Member 000 0000